SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018902
Filing Date
2024-05-13
Accepted
2024-05-13 16:27:20
Documents
89
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1087697
2 ex31-1.htm EX-31.1 20703
3 ex31-2.htm EX-31.2 20404
4 ex32-1.htm EX-32.1 9918
  Complete submission text file 0001493152-24-018902.txt   7023847

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20240331.xsd EX-101.SCH 54950
6 XBRL CALCULATION FILE hrow-20240331_cal.xml EX-101.CAL 81895
7 XBRL DEFINITION FILE hrow-20240331_def.xml EX-101.DEF 287074
8 XBRL LABEL FILE hrow-20240331_lab.xml EX-101.LAB 436381
9 XBRL PRESENTATION FILE hrow-20240331_pre.xml EX-101.PRE 378821
93 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1091689
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 24939464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)